Bradley W. McEvoy
Bradley W. McEvoy publishes mostly in Molecular Biology, Psychiatry and Mental health and Statistics and Probability, on topics such as Amyloidosis: Diagnosis, Treatment, Outcomes, Schizophrenia research and treatment and Genetic Neurodegenerative Diseases.
- World rank
- #2,483,488 of 7,710,434 ranked researchers
- Rank in United States
- #733,033 of 1,627,098
- Works
- 27
- Citations
- 2.5k
- Citations per work
- 91.1
What does Bradley W. McEvoy research?
Bradley W. McEvoy's work is mostly in Biochemistry, Genetics and Molecular Biology (19%), Medicine (19%), Mathematics (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1141.8%
- Life Sciences725.9%
- Health Sciences519.4%
- Medicine519.4%
- Physical Sciences28.1%
- Mathematics28.1%
- Social Sciences14.8%
- Arts and Humanities14.8%
- 1Molecular Biology19% of their works
- 2Psychiatry and Mental health11% of their works
- 3Statistics and Probability8% of their works
- 4Neurology8% of their works
- 5Cellular and Molecular Neuroscience6% of their works
- 6Philosophy5% of their works
Research topics
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Schizophrenia research and treatment
- Genetic Neurodegenerative Diseases
- Neurological Disorders and Treatments
- Statistical Methods in Clinical Trials
- Parkinson's Disease Mechanisms and Treatments
- Mental Health and Psychiatry
- Pharmacological Effects of Natural Compounds
Which keywords describe Bradley W. McEvoy's research?
The keywords of their largest research topics: Mitochondrial Dysfunction, Cardiac Amyloidosis, Oxidative Stress, Transthyretin, Antipsychotic Drugs, Neurocognitive Deficits, Huntington's Disease and Protein Aggregation.
- Licorice
- a-Synuclein
- Phenomenology
- False Discovery Rate
- Cerebrolysin
- Protein Aggregation
- Neurocognitive Deficits
- Transthyretin
- Cardiac Amyloidosis
- Mitochondrial Dysfunction
- Oxidative Stress
- Antipsychotic Drugs
- Huntington's Disease
- Adaptive Designs
- Citicoline
- Parkinson's Disease
- Psychiatric Disorders
- Glycyrrhizin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Mitochondrial Dysfunction103 topics
- Cardiac Amyloidosis61 topic
- Oxidative Stress62 topics
- Transthyretin61 topic
- Antipsychotic Drugs51 topic
- Neurocognitive Deficits51 topic
- Huntington's Disease41 topic
- Protein Aggregation41 topic
- Adaptive Designs31 topic
- Cerebrolysin31 topic
- Citicoline31 topic
- False Discovery Rate31 topic
- Parkinson's Disease31 topic
- Phenomenology31 topic
- Psychiatric Disorders31 topic
- a-Synuclein31 topic
- Glycyrrhizin21 topic
- Licorice21 topic
Where does Bradley W. McEvoy work?
Bradley W. McEvoy's main affiliation in the publication record is Acadia Pharmaceuticals (United States), United States.
How many publications and citations does Bradley W. McEvoy have?
OpenAlex counts 27 works and 2,459 citations for Bradley W. McEvoy, an h-index of 8, ranking #2,483,488 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Bradley W. McEvoy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.